Is it time to target no evident disease activity (NEDA) in multiple sclerosis?

The management of multiple sclerosis is becoming increasingly complex with the emergence of new and more effective disease-modifying therapies (DMT). We propose a new treatment paradigm that individualises treatment based on a choice between two interchangeable therapeutic strategies of maintenance-...

Full description

Saved in:

Bibliographic Details
Published in:	Multiple sclerosis and related disorders Vol. 4; no. 4; pp. 329 - 333
Main Authors:	Giovannoni, Gavin, Turner, Benjamin, Gnanapavan, Sharmilee, Offiah, Curtis, Schmierer, Klaus, Marta, Monica
Format:	Journal Article
Language:	English
Published:	Netherlands Elsevier B.V 01.07.2015
Subjects:	Algorithms Disease activity free Disease modifying therapy Disease Progression Humans Magnetic Resonance Imaging Multiple sclerosis Multiple Sclerosis - pathology Multiple Sclerosis - physiopathology Multiple Sclerosis - therapy NEDA Neurology No evident disease activity Precision Medicine - methods Treating to target Treatment Outcome NEDA Disease modifying therapy Multiple sclerosis Disease activity free No evident disease activity Treating to target
ISSN:	2211-0348, 2211-0356, 2211-0356
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!

Be the first to leave a comment!